Speaker illustration

Doctor Liliana Reis

Hospital Centre do Tamega e Sousa, Penafiel (Portugal)

Takotsubo cardiomyopathy: predictors of early left ventricular systolic function recovery. A portuguese multicenter study

Event: EuroEcho-Imaging 2017

Topic: TakoTsubo cardiomyopathy

Session: Cardiomyopathies

Thumbnail

Physical triggers in patients of takotsubo cardiomyopathy. a different prognosis?

Event: EuroEcho-Imaging 2017

Topic: TakoTsubo cardiomyopathy

Session: Cardiomyopathies

Thumbnail

Gender-correlated differences in a population with hypertrophic cardiomyopathy. A portuguese multicenter study.

Event: EuroEcho-Imaging 2017

Topic: Hypertrophic cardiomyopathy

Session: Up-to-date research on left ventricular function

Thumbnail

Impact of nitrate use on morbility and mortality in acute heart failure

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Acute heart failure (management)

Session: Rapid Fire 7 - Acute heart failure

Thumbnail

Left atrial size and acute coronary syndromes. Let is make simple.

Event: EuroEcho-Imaging 2016

Topic: Myocardial infarction

Session: Ischemic heart disease

Thumbnail

Mortality risk factors in patients with Takotsubo cardiomyopathy. Portuguese multicentre study.

Event: Acute Cardiovascular Care 2016

Topic: Myocardial and pericardial diseases

Session: Moderated Posters Session 5: General intensive care

Thumbnail

Predictors of atrial fibrillation in hypertrophic cardiomyopathy patients.

Event: Acute Cardiovascular Care 2016

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation

Thumbnail

Iron deficiency and anemia in acute heart failure: a problem?

Event: HEART FAILURE 2016

Topic: Acute heart failure (other)

Session: Acute heart failure

Thumbnail

Prevalence of left ventricular systolic dysfunction in a portuguese population of left ventricular non-compaction cardiomyopathy - A multicentre study

Event: HEART FAILURE 2016

Topic: Cardiomyopathies

Session: Cardiomyopathy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk